S'abonner

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response - 01/08/14

Doi : 10.1016/j.jaci.2014.03.009 
Nikhil Dhingra, BS a, b, , Avner Shemer, MD c, , Joel Correa da Rosa, PhD e, Mariya Rozenblit, BA a, d, e, Judilyn Fuentes-Duculan, MD a, Julia K. Gittler, MD a, f, Robert Finney, MD a, g, Tali Czarnowicki, MD a, e, Xiuzhong Zheng, MSc a, Hui Xu, MSc a, Yeriel D. Estrada, BS a, d, Irma Cardinale, MSc a, Mayte Suárez-Fariñas, PhD a, e, James G. Krueger, MD, PhD a, e, Emma Guttman-Yassky, MD, PhD a, d,
a Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY 
b Columbia University College of Physicians & Surgeons, New York, NY 
c Department of Dermatology, Tel-Hashomer, Tel Aviv, Israel 
d Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 
e Center for Clinical and Translational Science, The Rockefeller University, New York, NY 
f Department of Dermatology, New York University School of Medicine, New York, NY 
g Department of Dermatology, Jefferson Medical College, Philadelphia, Pa 

Corresponding author: Emma Guttman-Yassky, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.

Abstract

Background

Allergic contact dermatitis (ACD) is the most common occupational disease. Although murine contact hypersensitivity provides a framework for understanding ACD, it carries important differences from its human counterpart. Unlike the contact hypersensitivity model, which is induced by potent sensitizers (ie, dinitrofluorobenzene), human ACD is induced by weak-to-moderate sensitizers (ie, nickel), which cannot induce reactions in mice. Distinct hapten-specific immune-polarizing responses to potent inducers were suggested in mice, with unclear relevance to human ACD.

Objective

We explored the possibility of distinct T-cell polarization responses in skin to common clinically relevant ACD allergens.

Methods

Gene-expression and cellular studies were performed on common allergens (ie, nickel, fragrance, and rubber) compared with petrolatum-occluded skin, using RT-PCR, gene arrays, and immunohistochemistry.

Results

Despite similar clinical reactions in all allergen groups, distinct immune polarizations characterized different allergens. Although the common ACD transcriptome consisted of 149 differentially expressed genes across all allergens versus petrolatum, a much larger gene set was uniquely altered by individual allergens. Nickel demonstrated the highest immune activation, with potent inductions of innate immunity, TH1/TH17 and a TH22 component. Fragrance, and to a lesser extent rubber, demonstrated a strong TH2 bias, some TH22 polarization, and smaller TH1/TH17 contributions.

Conclusions

Our study offers new insights into the pathogenesis of ACD, expanding the understanding of T-cell activation and associated cytokines in allergen-reactive tissues. It is the first study that defines the common transcriptome of clinically relevant sensitizers in human skin and identifies unique pathways preferentially activated by different allergens, suggesting that ACD cannot be considered a single entity.

Le texte complet de cet article est disponible en PDF.

Key words : Allergic contact dermatitis, patch testing, T-cell polarization, human skin, allergens, nickel, fragrance, rubber

Abbreviations used : ACD, AD, CCL13, CCL17, CCL18, CCL26, CHS, CTLA4, CXCL1, CXCL2, CXCL9, CXCL10, CXCL11, DC, DEG, IHC, PI3, RT-PCR, S100A


Plan


 J.G.K., M.S.-F., J.C.d.R., M.R., T.C., and N.D. were supported by the National Center for Research Resources (NCRR) (grant no. 5UL1RR024143-02), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. E.G.-Y. was supported by the Dermatology Foundation Physician Scientist Career Development Award.
 Disclosure of potential conflict of interest: Y. D. Estrada has received research support from the National Institutes of Health. J. G. Krueger has received consultancy fees from Centocor, Lilly, and Pfizer and has received research support from Amgen, Centocor, Lilly, Merck, and Pfizer. E. Guttman-Yassky has received research support from Novartis, Janssen, Leo-Pharma, Bristol Meyers Squib, Dermira, Celgene, and Regeneron and has received personal fees from Leo-Pharma, Genentech, Dermira, Celgene, Stiefel/GSK, Pfizer, Medimmune, Anaptysbio, and Regeneron. The rest of the authors declare that they have no relevant conflicts of interest.


© 2014  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 134 - N° 2

P. 362-372 - août 2014 Retour au numéro
Article précédent Article précédent
  • Allergic sensitization is a key risk factor for but not synonymous with allergic disease
  • Robert G. Hamilton
| Article suivant Article suivant
  • Thymic stromal lymphopoietin links keratinocytes and dendritic cell–derived IL-23 in patients with psoriasis
  • Elisabetta Volpe, Lucia Pattarini, Carolina Martinez-Cingolani, Stephan Meller, Marie-Helene Donnadieu, Sofia I. Bogiatzi, Maria I. Fernandez, Maxime Touzot, Jean-Christophe Bichet, Fabien Reyal, Maria Paola Paronetto, Andrea Chiricozzi, Sergio Chimenti, Francesca Nasorri, Andrea Cavani, Andreas Kislat, Bernhard Homey, Vassili Soumelis

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.